LYKALABS

Lyka Labs Limited · NSE · INE933A01014 · 186 sessions on record

₹74.83▲ +0.88 · +1.2%from ₹73.95 the session before · 1 Jul 2026 close · NSE end of day

Open: ₹74.81
High: ₹77.00
Low: ₹72.70
Day's range: ₹4.35.8% of the previous close
VWAP: ₹75.22close −0.51% from it
Volume, shares: 89,0000.98× the 20-session average
Turnover, ₹ crore: 0.67
Trades: 1,20076 shares per trade
Previous close: ₹73.95+0.88 to the close
Price band, next session: ₹67.35 – ₹82.3010% either side of the close · dynamic, widened in 5% steps when hit

Day range50% of the way up

₹72.70₹77.00

52-week range53% of the way up

₹44.10 30 Mar₹102.55 2 Sept

−27% from the high · +70% from the low

Futures and options

No derivatives listed on LYKALABS

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Jul · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

186 sessions on file · from 28 Aug

LYKALABS close
Nifty 50, rebased

Session read · latest close: 1 Jul 2026
Close ₹ · day %: ₹74.83▲ +1.2% on the previous close
Against Nifty 50: Nifty +0.6%+0.6 pp difference on the day
Against the averages: above 20 · above 5020-session ₹68.62 (+9.0%) · 50-session ₹60.86 (+23%)
Volume: 0.98×the previous 20 sessions · 89,000 shares
Extremes on the day: none

Quarterly results

consolidated · latest filed 10 Aug, 02:30 pm IST · NSE filings

Revenue ₹42 cr; profit ₹2 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of LYKALABS on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 10 Aug	₹42 cr	—	₹2 cr	—	0.57	—not reached
Mar 2026filed 25 May · audited	₹28 cr	—	−₹8 cr	—	-2.13	▼ −3.1%Nifty −0.5% · −2.6 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹74.83 on 1 Jul

Fundamentals for LYKALABS on the consolidated basis to Jun 2026.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: —no NSE market-cap record yet
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: —no NSE market-cap record yet
Book value a share: —no NSE share count yet
Debt to equity: 0.53borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity: —needs two filed balance sheets
Dividend yield: —no dividend with an ex-date in 365 days
Face value: —no NSE record yet
Shares outstanding: —no NSE record yet

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Pharmaceuticals · F&O stocks with filings on record · industry P/E 38, market caps over trailing profit of 13 stocks

Stocks in the BSE sub-group Pharmaceuticals with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
SUNPHARMASun Pharmaceutical Industries Limited	4,30,000 cron 1 Oct	36consolidated	5.2	₹1,801.00
DIVISLABDivi's Laboratories Limited	2,50,000 cron 1 Oct	52consolidated	15	₹9,249.00
TORNTPHARMTorrent Pharmaceuticals Limited	1,80,000 cron 1 Oct	76consolidated	10	₹4,767.30
ZYDUSLIFEZydus Lifesciences Limited	1,10,000 cron 1 Oct	26consolidated	3.9	₹1,145.70
CIPLACipla Limited	1,10,000 cron 1 Oct	32consolidated	3.1	₹1,344.00
LAURUSLABSLaurus Labs Limited	1,10,000 cron 1 Oct	85consolidated	20	₹1,984.00
MANKINDMankind Pharma Limited	1,00,000 cron 1 Oct	51consolidated	6.3	₹2,535.00
DRREDDYDr. Reddy's Laboratories Limited	1,00,000 cron 1 Oct	31consolidated	2.6	₹1,206.20
AUROPHARMAAurobindo Pharma Limited	96,000 cron 1 Oct	26consolidated	2.5	₹1,676.80
LUPINLupin Limited	93,000 cron 1 Oct	17consolidated	4.1	₹2,031.20
GLENMARKGlenmark Pharmaceuticals Limited	66,000 cron 1 Oct	37consolidated	6.3	₹2,331.00
ALKEMAlkem Laboratories Limited	62,000 cron 1 Oct	29consolidated	4.3	₹5,220.00
BIOCONBiocon Limited	60,000 cron 1 Oct	110consolidated	1.6	₹370.70
ABBOTINDIAAbbott India Limited	57,000 cron 1 Oct	—	—	₹26,840.00
IPCALABIPCA Laboratories Limited	49,000 cron 1 Oct	—	5.2	₹1,943.20
GLANDGland Pharma Limited	47,000 cron 1 Oct	—	4.6	₹2,874.40
GLAXOGlaxoSmithKline Pharmaceuticals Limited	47,000 cron 1 Oct	—	21	₹2,771.10
AJANTPHARMAjanta Pharma Limited	45,000 cron 1 Oct	—	9.9	₹3,581.00
EMCUREEmcure Pharmaceuticals Limited	37,000 cron 1 Oct	—	7.4	₹1,944.60
WOCKPHARMAWockhardt Limited	34,000 cron 1 Oct	—	6.4	₹2,083.90
SAILIFESai Life Sciences Limited	33,000 cron 1 Oct	—	13	₹1,541.20
NEULANDLABNeuland Laboratories Limited	28,000 cron 1 Oct	—	15	₹21,505.00
RUBICONRubicon Research Limited	27,000 cron 1 Oct	—	21	₹1,630.90
PPLPHARMAPiramal Pharma Limited	26,000 cron 1 Oct	—	3.2	₹197.95
ACUTAASAcutaas Chemicals Limited	26,000 cron 1 Oct	—	15	₹3,196.50
SHILPAMEDShilpa Medicare Limited	21,000 cron 1 Oct	—	8.0	₹1,064.10
GRANULESGranules India Limited	20,000 cron 1 Oct	—	4.0	₹821.75
CAPLIPOINTCaplin Point Laboratories Limited	20,000 cron 1 Oct	—	5.5	₹2,631.90
PFIZERPfizer Limited	18,000 cron 1 Oct	—	4.2	₹3,858.90
ONESOURCEOnesource Specialty Pharma Limited	17,000 cron 1 Oct	—	3.0	₹1,508.00
COHANCECohance Lifesciences Limited	17,000 cron 1 Oct	—	4.3	₹451.30
ALIVUSAlivus Life Sciences Limited	17,000 cron 1 Oct	—	5.1	₹1,374.20
ERISEris Lifesciences Limited	16,000 cron 1 Oct	—	4.2	₹1,189.80
NATCOPHARMNatco Pharma Limited	16,000 cron 1 Oct	—	1.8	₹821.30
APLLTDAlembic Pharmaceuticals Limited	16,000 cron 1 Oct	—	2.8	₹815.25
JUBLPHARMAJubilant Pharmova Limited	16,000 cron 1 Oct	—	2.2	₹999.30
ASTRAZENAstraZeneca Pharma India Limited	15,000 cron 1 Oct	—	17	₹6,031.00
MARKSANSMarksans Pharma Limited	15,000 cron 1 Oct	—	4.8	₹325.60
CONCORDBIOConcord Biotech Limited	14,000 cron 1 Oct	—	7.1	₹1,374.10
AKUMSAkums Drugs and Pharmaceuticals Limited	13,000 cron 1 Oct	—	3.8	₹813.10
CORONACORONA Remedies Limited	12,000 cron 1 Oct	—	17	₹2,029.40
BLUEJETBlue Jet Healthcare Limited	10,000 cron 1 Oct	—	7.5	₹541.80
VIYASHViyash Scientific Limited	10,000 cron 1 Oct	—	3.3	₹231.75
STARStrides Pharma Science Limited	10,000 cron 1 Oct	—	3.2	₹1,084.80
PGHLProcter & Gamble Health Limited	8,900 cron 1 Oct	—	17	₹5,360.00
AARTIPHARMAarti Pharmalabs Limited	8,800 cron 1 Oct	—	4.1	₹968.50
SANOFICONRSanofi Consumer Healthcare India Limited	8,700 cron 1 Oct	—	25	₹3,787.20
SYMBIOTECSymbiotec Pharmalab Limited	7,700 cron 1 Oct	—	—	₹1,198.00
SUPRIYASupriya Lifescience Limited	7,500 cron 1 Oct	—	6.3	₹931.00
MOREPENLABMorepen Laboratories Limited	7,300 cron 1 Oct	—	5.9	₹133.70
SANOFISanofi India Limited	7,000 cron 1 Oct	—	8.5	₹3,037.40
INNOVACAPInnova Captab Limited	6,700 cron 1 Oct	—	6.1	₹1,168.00
SPARCSun Pharma Advanced Research Company Limited	6,300 cron 1 Oct	—	4.7	₹194.15
SENORESSenores Pharmaceuticals Limited	6,200 cron 1 Oct	—	6.4	₹1,349.60
IOLCPIOL Chemicals and Pharmaceuticals Limited	6,100 cron 1 Oct	—	3.4	₹209.40
ORCHPHARMAOrchid Pharma Limited	5,900 cron 1 Oct	—	4.6	₹990.00
FDCFDC Limited	5,500 cron 1 Oct	—	2.2	₹335.90
GUJTHEMGujarat Themis Biosyn Limited	5,000 cron 1 Oct	—	—	₹381.80
NOVARTINDNovartis India Limited	4,900 cron 1 Oct	—	—	₹1,965.00
RPGLIFERPG Life Sciences Limited	4,800 cron 1 Oct	—	8.0	₹2,930.70
SMSPHARMASMS Pharmaceuticals Limited	4,400 cron 1 Oct	—	5.6	₹471.30
GUFICBIOGufic Biosciences Limited	4,200 cron 1 Oct	—	6.3	₹418.40
AARTIDRUGSAarti Drugs Limited	3,800 cron 1 Oct	—	2.5	₹421.00
UNICHEMLABUnichem Laboratories Limited	3,800 cron 1 Oct	—	1.4	₹535.05
KPLKwality Pharmaceuticals Limited	3,700 cron 1 Oct	—	—	₹3,564.40
SOLARASolara Active Pharma Sciences Limited	3,400 cron 1 Oct	—	2.7	₹714.85
INDSWFTLABInd-Swift Laboratories Limited	3,400 cron 1 Oct	—	2.5	₹395.15
SHUKRAPHARShukra Pharmaceuticals Limited	2,700 cron 1 Oct	—	—	₹61.80
HIKALHikal Limited	2,700 cron 1 Oct	—	2.2	₹218.15
VENUSREMVenus Remedies Limited	2,400 cron 1 Oct	—	3.6	₹1,796.70
DCALDishman Carbogen Amcis Limited	2,400 cron 1 Oct	—	0.35	₹150.35
INDOCOIndoco Remedies Limited	2,300 cron 1 Oct	—	2.5	₹251.75
SAIPARENTSai Parenterals Limited	2,300 cron 1 Oct	—	4.7	₹523.65
SYNCOMFSyncom Formulations (India) Limited	2,300 cron 1 Oct	—	5.4	₹23.95
FREDUNFredun Pharmaceuticals Limited	2,200 cron 1 Oct	—	—	₹1,355.20
WINDLASWindlas Biotech Limited	2,200 cron 1 Oct	—	—	₹1,082.40
PANACEABIOPanacea Biotec Limited	2,200 cron 1 Oct	—	2.6	₹359.05
HESTERBIOHester Biosciences Limited	1,800 cron 1 Oct	—	4.9	₹2,126.80
NGLFINENGL Fine-Chem Limited	1,800 cron 1 Oct	—	5.5	₹2,924.00
AHCLAnlon Healthcare Limited	1,700 cron 1 Oct	—	6.8	₹32.85
FERMENTAFermenta Biotech Limited	1,600 cron 1 Oct	—	—	₹553.25
JAGSNPHARMJagsonpal Pharmaceuticals Limited	1,500 cron 1 Oct	—	5.5	₹231.75
AMRUTANJANAmrutanjan Health Care Limited	1,500 cron 1 Oct	—	4.0	₹513.20
KOPRANKopran Limited	1,400 cron 1 Oct	—	2.6	₹282.05
BPLPHARMABharat Parenterals Limited	1,200 cron 1 Oct	—	—	₹1,720.40
LINCOLNLincoln Pharmaceuticals Limited	1,200 cron 1 Oct	—	1.5	₹582.05
BAJAJHCAREBajaj Healthcare Limited	1,100 cron 1 Oct	—	2.0	₹322.95
SIGACHISigachi Industries Limited	1,100 cron 1 Oct	—	2.0	₹28.35
THEMISMEDThemis Medicare Limited	1,000 cron 1 Oct	—	2.6	₹113.20
SGRLShree Ganesh Remedies Limited	890 cron 1 Oct	—	—	₹694.25
ANUHPHRAnuh Pharma Limited	860 cron 1 Oct	—	2.4	₹85.85
ZIMLABZim Laboratories Limited	740 cron 1 Oct	—	2.5	₹137.00
WANBURYWanbury Limited	690 cron 1 Oct	—	4.8	₹198.00
ALBERTDAVDAlbert David Limited	490 cron 1 Oct	—	1.3	₹856.70
MEDICAMEQMedicamen Biotech Limited	470 cron 17 Sept	—	1.7	₹346.30
HALEOSLABSHALEOS LABS LIMITED	450 cron 1 Oct	—	2.0	₹1,490.00
JENBURPHJenburkt Pharmaceuticals Limited	400 cron 1 Oct	—	—	₹915.25
AAREYDRUGSAarey Drugs & Pharmaceuticals Limited	290 cron 1 Oct	—	2.0	₹103.85
NECLIFENectar Lifesciences Limited	200 cron 1 Oct	—	0.34	₹10.25
MEDICOMedico Remedies Limited	180 cron 1 Oct	—	2.4	₹21.85
BALPHARMABal Pharma Limited	170 cron 1 Oct	—	2.0	₹105.75
BROOKSBrooks Laboratories Limited	160 cron 1 Oct	—	1.3	₹54.80
KREBSBIOKrebs Biochemicals and Industries Limited	150 cron 1 Oct	—	—	₹68.05
PARNAXLABParnax Lab Limited	130 cron 1 Oct	—	—	₹113.15
ALPAAlpa Laboratories Limited	120 cron 1 Oct	—	0.67	₹59.25
MAKERSLMakers Laboratories Limited	110 cron 1 Oct	—	—	₹183.50
SUNLOCSunil Healthcare Limited	72 cron 1 Oct	—	—	₹70.10
VINEETLABVineet Laboratories Limited	69 cron 1 Oct	—	1.5	₹35.90
BIOFILCHEMBiofil Chemicals & Pharmaceuticals Limited	48 cron 1 Oct	—	2.2	₹29.30
MANGALAMMangalam Drugs And Organics Limited	46 cron 1 Oct	—	0.45	₹29.15
MEDICAPQMedi Caps Limited	31 cron 17 Sept	—	—	₹24.80
ORTINGLOBEORTIN GLOBAL LIMITED	12 cron 1 Oct	—	9.5	₹14.50
AMANTAAmanta Healthcare Limited	—	—	—	—
AMBALALSAAmbalal Sarabhai Enterprises Limited	—	—	—	—
BAFNAPHBafna Pharmaceuticals Limited	—	—	—	—
BLISSGVSBliss GVS Pharma Limited	—	—	—	—
KILITCHKilitch Drugs (India) Limited	—	—	—	—
LASALasa Supergenerics Limited	—	—	—	—
LYKALABSLyka Labs Limited	—	—	—	—
NATCAPSUQNatural Capsules Limited	—	—	—	—
VALIANTLABValiant Laboratories Limited	—	—	—	—
VIVIMEDLABVivimed Labs Limited	—	—	—	—

Shareholding

quarter to 30 Jun · none pledged · NSE filings

Promoters hold 58.5%, foreign portfolio investors 0.2%, mutual funds 0.0% and insurance companies 0.3%, as filed for the quarter to 30 Jun.

58.5%32.3%

By category, last 2 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of LYKALABS by category over the last 2 quarters with the change against the previous quarter
Category	30 Jun	31 Mar
Promoters	58.45▲ +0.29 pp	58.16
Foreign portfolio investors	0.17▼ −0.12 pp	0.29
Mutual funds	0.010.00 pp	0.01
Insurance companies	0.280.00 pp	0.28
Banks and financial institutions	0.370.00 pp	0.37
Individual investors	32.27▲ +0.14 pp	32.13
Bodies corporate	4.39▼ −0.08 pp	4.47
Others	4.07▼ −0.22 pp	4.29

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a Annual General Meeting, ex-date 1 Aug 2024.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios

Corporate actions of LYKALABS, upcoming first, then the most recent
Ex-date	Action	Amount or ratio	Record date	Source
recent
1 Aug 2024	otherAnnual General Meeting	—	—	NSE

Calendaras notified to the exchange

Next results: —no board meeting notified yet
Dividends in 365 days: —a share · ex-dates inside the year
Last dividend: —none on record

Price history

186 sessions on record · to 1 Jul · NSE end of day

LYKALABS is +29.2% over 20 sessions against Nifty's +2.2%, 27% below its 52-week high, realised volatility 54% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	LYKALABS %	Nifty 50 %	Difference pp
120 sessionssince 2 Dec	₹85.20	▼ −12%	▼ −7.8%	−4.4
60 sessionssince 26 Feb	₹64.50	▲ +16%	▼ −5.8%	+22
20 sessionssince 2 Jun	₹57.93	▲ +29%	▲ +2.2%	+27
5 sessionssince 23 Jun	₹67.30	▲ +11%	▲ +0.76%	+10
1 sessionsince 30 Jun	₹73.95	▲ +1.2%	▲ +0.59%	+0.60

Averages of the closeclose against each average

5-session average: ₹72.42close +3.3% from it
20-session average: ₹68.62close +9.0% from it
50-session average: ₹60.86close +23% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹4.45.9% of the close
Average day's range, 20: ₹5.37.0% of the close
Volume against 20 sessions: 0.98×89,000 vs 94,000 average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 54%≈ ±3.4% a session · moved more than that on 8 of 20
Realised volatility, 60: 66%≈ ±4.1% a session · moved more than that on 15 of 60
Beta to Nifty, 60: 1.42moved with Nifty on 39 of 60 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 13 up · 7 downof 20
Last 60 sessions: 31 up · 29 downof 60
Best session, 250: ▲ +14%1 Apr
Worst session, 250: ▼ −9.3%23 Mar

0 bulletins on LYKALABS

The desk has not written about Lyka Labs Limited yet. The tape carries every bulletin as it is published.

About Lyka Labs Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Lyka Labs Limited
Exchange: NSE · BSE 500259, group T
Listed on NSE: 8 Feb 1995
Classification: Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
Face value: ₹10 a share
ISIN: INE933A01014
Sessions on record: 186
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 2 Oct, 02:26 am IST
Bulletins: 0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.